Title : Metformin Antagonizes Ovarian Cancer Cells Malignancy Through MSLN Mediated IL-6/STAT3 Signaling.

Pub. Date : 2021 Jan-Dec

PMID : 34238029






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin Antagonizes Ovarian Cancer Cells Malignancy Through MSLN Mediated IL-6/STAT3 Signaling. Metformin signal transducer and activator of transcription 3 Homo sapiens
2 On mechanism, metformin treatment remarkably reduced mesothelin (MSLN) expression, downregulated IL-6/STAT3 signaling activity, subsequently resulted in VEGF and TGFbeta1 expression. Metformin signal transducer and activator of transcription 3 Homo sapiens
3 CONCLUSIONS: Collectively, our findings suggested that metformin exerts anticancer effects by suppressing ovarian cancer cell malignancy, which attributed to MSLN inhibition mediated IL6/STAT3 signaling and VEGF and TGFbeta1 downregulation. Metformin signal transducer and activator of transcription 3 Homo sapiens